{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:16:07Z","timestamp":1783386967383,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UL1TR001442"],"award-info":[{"award-number":["UL1TR001442"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 DK120515"],"award-info":[{"award-number":["P30 DK120515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014042","name":"Department of Defense Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-20-1-0675"],"award-info":[{"award-number":["W81XWH-20-1-0675"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.isci.2024.109457","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T16:56:50Z","timestamp":1709917010000},"page":"109457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies"],"prefix":"10.1016","volume":"27","author":[{"given":"Prerna","family":"Bali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"Lozano-Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica V.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maripat","family":"Corr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Benner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-8404","authenticated-orcid":false,"given":"Marygorret","family":"Obonyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109457_bib1","first-page":"1","article-title":"Schistomes, liver flukes and Helicobacter pylori. IARC Monographs on the evaluation of carcinogenesis risks to humans","volume":"61","year":"1994","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.isci.2024.109457_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","article-title":"Helicobacter pylori and gastrointestinal tract adenocarcinomas","volume":"2","author":"Peek","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global Cancer Incidence and Mortality Rates and Trends--An Update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.isci.2024.109457_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI30111","article-title":"Inflammation, atrophy, and gastric cancer","volume":"117","author":"Fox","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.109457_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","article-title":"The gastric precancerous cascade","volume":"13","author":"Correa","year":"2012","journal-title":"J.\u00a0Dig. Dis."},{"key":"10.1016\/j.isci.2024.109457_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.01344-13","article-title":"Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter-induced gastric malignancy","volume":"82","author":"Banerjee","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2024.109457_bib8","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-07-6786","article-title":"Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice","volume":"68","author":"Lee","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2024.109457_bib9","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/carcin\/bgm071","article-title":"Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice","volume":"28","author":"Stenstr\u00f6m","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.isci.2024.109457_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12885-017-3114-y","article-title":"Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer","volume":"17","author":"Lozano-Pope","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103064","article-title":"The TLR4-TRIF-type 1 IFN-IFN-gamma pathway is crucial for gastric MALT lymphoma formation after Helicobacter suis infection","volume":"24","author":"Yamamoto","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2024.109457_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","article-title":"TLR signaling","volume":"13","author":"Kawai","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2024.109457_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nature01889","article-title":"Identification of Lps2 as a key transducer of MyD88-independent TIR signalling","volume":"424","author":"Hoebe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109457_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni886","article-title":"TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction","volume":"4","author":"Oshiumi","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2024.109457_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.109457_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.109457_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cncr.10375","article-title":"Patterns of gastric atrophy in intestinal type gastric carcinoma","volume":"94","author":"El-Zimaity","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/B978-0-12-381280-3.00005-1","article-title":"Oxyntic atrophy, metaplasia, and gastric cancer","volume":"96","author":"Goldenring","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.isci.2024.109457_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1755-8794-6-41","article-title":"Transcriptome signatures in Helicobacter pylori-infected mucosa identifies acidic mammalian chitinase loss as a corpus atrophy marker","volume":"6","author":"Nookaew","year":"2013","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.isci.2024.109457_bib20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1053\/j.gastro.2021.06.078","article-title":"AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review","volume":"161","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.109457_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109457_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109457_bib23","doi-asserted-by":"crossref","first-page":"49322","DOI":"10.18632\/oncotarget.10337","article-title":"Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients","volume":"7","author":"Sz\u00e1sz","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2024.109457_bib24","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1158\/1078-0432.CCR-13-3049","article-title":"A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response","volume":"20","author":"Busuttil","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109457_bib25","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/IAI.01794-06","article-title":"Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori","volume":"75","author":"Obonyo","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2024.109457_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ijc.23944","article-title":"Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomas","volume":"124","author":"Guimar\u00e3es","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib27","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1074\/jbc.M110542200","article-title":"The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation","volume":"277","author":"Gorbacheva","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.109457_bib28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.leukres.2008.06.014","article-title":"Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma","volume":"33","author":"Corm","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.isci.2024.109457_bib29","doi-asserted-by":"crossref","DOI":"10.4161\/onci.23428","article-title":"Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer","volume":"2","author":"Creelan","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2024.109457_bib30","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.981457","article-title":"Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival","volume":"4","author":"Ferns","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2024.109457_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2009.07.015","article-title":"Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma","volume":"115","author":"Inaba","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2024.109457_bib32","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-07-4144","article-title":"Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival","volume":"14","author":"Ino","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109457_bib33","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ejca.2011.09.007","article-title":"Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients","volume":"48","author":"Speeckaert","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib34","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1158\/1078-0432.CCR-12-2130","article-title":"IDO expression in brain tumors increases the recruitment of regulatory T\u00a0cells and negatively impacts survival","volume":"18","author":"Wainwright","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109457_bib35","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6603477","article-title":"Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer","volume":"95","author":"Ino","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib36","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1158\/1078-0432.CCR-04-2671","article-title":"Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells","volume":"11","author":"Okamoto","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109457_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2018.12.004","article-title":"Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence","volume":"196","author":"Ricciuti","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2024.109457_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejca.2017.01.011","article-title":"The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy","volume":"76","author":"Brochez","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/bjc.2011.513","article-title":"Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer","volume":"106","author":"Ferdinande","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib40","doi-asserted-by":"crossref","first-page":"10239","DOI":"10.2147\/OTT.S226395","article-title":"Inhibition of ISG15 Enhances the Anti-Cancer Effect of Trametinib in Colon Cancer Cells","volume":"12","author":"Zhou","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.isci.2024.109457_bib41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1469-0691.2009.03031.x","article-title":"Helicobacter pylori and gastric adenocarcinoma","volume":"15","author":"Herrera","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.isci.2024.109457_bib42","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrc2857","article-title":"Helicobacter pylori: gastric cancer and beyond","volume":"10","author":"Polk","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2024.109457_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2013-305092","article-title":"Obesity accelerates Helicobacter felis-induced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response","volume":"63","author":"Ericksen","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.isci.2024.109457_bib45","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/j.gastro.2005.02.066","article-title":"Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL\/6 mice","volume":"128","author":"Cai","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.109457_bib46","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/00365529609006406","article-title":"The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels","volume":"31","author":"H\u00f6\u00f6k-Nikanne","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.109457_bib47","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.3390\/curroncol29070375","article-title":"Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5","volume":"29","author":"Hernandez","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.isci.2024.109457_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/microorganisms9010189","article-title":"Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis","volume":"9","author":"Bali","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.isci.2024.109457_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3892\/ijo.2021.5171","article-title":"Early detection of tumor cells in bone marrow and peripheral blood in a fastprogressing gastric cancer model","volume":"58","author":"Bali","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.isci.2024.109457_bib50","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1038\/s41598-019-43417-x","article-title":"Increased LIGHT expression and activation of non-canonical NF-kappaB are observed in gastric lesions of MyD88-deficient mice upon Helicobacter felis infection","volume":"9","author":"Mej\u00edas-Luque","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109457_bib51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1523-5378.2011.00861.x","article-title":"Effects of myeloid differentiation primary response gene 88 (MyD88) activation on Helicobacter infection in\u00a0vivo and induction of a Th17 response","volume":"16","author":"Obonyo","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.isci.2024.109457_bib52","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1158\/0008-5472.CAN-05-1846","article-title":"Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice","volume":"65","author":"Rogers","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2024.109457_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.109457_bib54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2024.109457_bib55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2024.109457_bib56","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109457_bib57","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","article-title":"Java Treeview--extensible visualization of microarray data","volume":"20","author":"Saldanha","year":"2004","journal-title":"Bioinformatics"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224006783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224006783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:57:06Z","timestamp":1783385826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224006783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2589004224006783"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109457","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRIF-IFN-I pathway in Helicobacter-induced gastric cancer in an accelerated murine disease model and patient biopsies","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109457"}}